Invention Grant
- Patent Title: Inhibitors of RAF kinases
-
Application No.: US17477260Application Date: 2021-09-16
-
Publication No.: US11407737B2Publication Date: 2022-08-09
- Inventor: Stephen W. Kaldor , Toufike Kanouni , John Tyhonas , Eric Murphy , Jason Cox , Robert Kania
- Applicant: Kinnate Biopharma Inc.
- Applicant Address: US CA San Diego
- Assignee: Kinnate Biopharma Inc.
- Current Assignee: Kinnate Biopharma Inc.
- Current Assignee Address: US CA San Diego
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D413/14 ; C07D401/12 ; C07D471/08 ; C07D265/30 ; C07D417/14
Abstract:
Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
Public/Granted literature
- US20220089569A1 INHIBITORS OF RAF KINASES Public/Granted day:2022-03-24
Information query
